- Home
- SCKT vs BOLT Comparison
SCKT vs BOLT Comparison
Compare SCKT & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCKT
- BOLT
- Stock Information
- Founded
- SCKT 1992
- BOLT 2015
- Country
- SCKT United States
- BOLT United States
- Employees
- SCKT N/A
- BOLT N/A
- Industry
- SCKT Computer Manufacturing
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- SCKT Technology
- BOLT Health Care
- Exchange
- SCKT Nasdaq
- BOLT Nasdaq
- Market Cap
- SCKT 9.8M
- BOLT 9.4M
- IPO Year
- SCKT 1995
- BOLT 2021
- Fundamental
- Price
- SCKT $1.05
- BOLT $4.89
- Analyst Decision
- SCKT
- BOLT Buy
- Analyst Count
- SCKT 0
- BOLT 3
- Target Price
- SCKT N/A
- BOLT $47.50
- AVG Volume (30 Days)
- SCKT 17.0K
- BOLT 14.3K
- Earning Date
- SCKT 10-23-2025
- BOLT 08-14-2025
- Dividend Yield
- SCKT N/A
- BOLT N/A
- EPS Growth
- SCKT N/A
- BOLT N/A
- EPS
- SCKT N/A
- BOLT N/A
- Revenue
- SCKT $16,710,984.00
- BOLT $4,167,000.00
- Revenue This Year
- SCKT $8.62
- BOLT N/A
- Revenue Next Year
- SCKT N/A
- BOLT N/A
- P/E Ratio
- SCKT N/A
- BOLT N/A
- Revenue Growth
- SCKT N/A
- BOLT N/A
- 52 Week Low
- SCKT $0.85
- BOLT $4.59
- 52 Week High
- SCKT $1.72
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- SCKT 48.49
- BOLT 37.48
- Support Level
- SCKT $1.01
- BOLT $4.81
- Resistance Level
- SCKT $1.09
- BOLT $5.28
- Average True Range (ATR)
- SCKT 0.06
- BOLT 0.27
- MACD
- SCKT 0.01
- BOLT -0.01
- Stochastic Oscillator
- SCKT 80.04
- BOLT 34.84
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.